TY - JOUR
T1 - Functional lipidomics. Calcium-independent activation of endocannabinoid/endovanilloid lipid signalling in sensory neurons by protein kinases C and A and thrombin
AU - Vellani, Vittorio
AU - Petrosino, Stefania
AU - De Petrocellis, Luciano
AU - Valenti, Marta
AU - Prandini, Massimiliano
AU - Magherini, Pier Cosimo
AU - McNaughton, Peter
AU - Di Marzo, Vincenzo
PY - 2008/12
Y1 - 2008/12
N2 - N-arachidonoylethanolamine (anandamide, AEA), is a full agonist at both cannabinoid CB, receptors and "transient receptor potential vanilloid" type I (TRPV1) channels, and N-palmitoylethanolamine (PEA) potentiates these effects. In neurons of the rat dorsal root ganglia (DRG), TRPV1 is activated and/or sensitised by AEA as well as upon activation of protein kinases C (PKC) and A (PKA). We investigated here the effect on AEA levels of PKC and PKA activators in DRG neurons. AEA levels were significantly enhanced by both phorbol-miristoyl-acetate (PMA), a typical PKC activator, and forskolin (FSK), an adenylate cyclase stimulant, as well as by thrombin, which also activates PKC by stimulating protease-activated receptors (PARs). The levels of the other endocannabinoid and TRPV1-inactive compound, 2-arachidonoylglycerol (2-AG), were enhanced only by thrombin and to a lesser extent than AEA, whereas PEA was not affected by any of the treatments. Importantly, FSK- and PMA-induced elevation of AEA levels was not sensitive to intracellular Ca(2+) chelation with BAPTA-acetoxymethyl (AM) ester. In human embryonic kidney (HEK-293) cells, which constitutively express PARs, thrombin, PMA and FSK elevated AEA levels, and the effects of the two former compounds were counteracted by the PKC inhibitor, RO318220, whereas the effect of FSK was reduced by the PKA inhibitor RpcAMPs. In conclusion, we report that AEA levels are stimulated by both PKC, either directly or after thrombin receptor activation, and PKA, possibly in a way independent from intracellular calcium. Since AEA activates TRPV1, these findings may suggest the existence of an amplificatory cascades on this receptor in sensory neurons. (C) 2008 Elsevier Ltd. All rights reserved.
AB - N-arachidonoylethanolamine (anandamide, AEA), is a full agonist at both cannabinoid CB, receptors and "transient receptor potential vanilloid" type I (TRPV1) channels, and N-palmitoylethanolamine (PEA) potentiates these effects. In neurons of the rat dorsal root ganglia (DRG), TRPV1 is activated and/or sensitised by AEA as well as upon activation of protein kinases C (PKC) and A (PKA). We investigated here the effect on AEA levels of PKC and PKA activators in DRG neurons. AEA levels were significantly enhanced by both phorbol-miristoyl-acetate (PMA), a typical PKC activator, and forskolin (FSK), an adenylate cyclase stimulant, as well as by thrombin, which also activates PKC by stimulating protease-activated receptors (PARs). The levels of the other endocannabinoid and TRPV1-inactive compound, 2-arachidonoylglycerol (2-AG), were enhanced only by thrombin and to a lesser extent than AEA, whereas PEA was not affected by any of the treatments. Importantly, FSK- and PMA-induced elevation of AEA levels was not sensitive to intracellular Ca(2+) chelation with BAPTA-acetoxymethyl (AM) ester. In human embryonic kidney (HEK-293) cells, which constitutively express PARs, thrombin, PMA and FSK elevated AEA levels, and the effects of the two former compounds were counteracted by the PKC inhibitor, RO318220, whereas the effect of FSK was reduced by the PKA inhibitor RpcAMPs. In conclusion, we report that AEA levels are stimulated by both PKC, either directly or after thrombin receptor activation, and PKA, possibly in a way independent from intracellular calcium. Since AEA activates TRPV1, these findings may suggest the existence of an amplificatory cascades on this receptor in sensory neurons. (C) 2008 Elsevier Ltd. All rights reserved.
KW - TRPV1
KW - CB1
KW - Anandamide
KW - 2-Arachidonoylglycerol
KW - Cannabinoid
KW - Signalling
KW - Vanilloid
KW - Channel
KW - Metabotropic
KW - RECEPTOR POTENTIAL VANILLOID-1
KW - CAPSAICIN RECEPTOR
KW - CANNABINOID RECEPTOR
KW - VR1 RECEPTORS
KW - ENDOGENOUS CANNABINOIDS
KW - THERMAL HYPERALGESIA
KW - TRPV1 CHANNELS
KW - ANANDAMIDE
KW - PHOSPHORYLATION
KW - RELEASE
U2 - 10.1016/j.neuropharm.2008.01.010
DO - 10.1016/j.neuropharm.2008.01.010
M3 - Article
SN - 0028-3908
VL - 55
SP - 1274
EP - 1279
JO - Neuropharmacology
JF - Neuropharmacology
IS - 8
ER -